Composition useful for the prevention of adverse effect due to the use of PPARgamma agonists

Details for Australian Patent Application No. 2008253134 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Inventors D'Iddio, Stefania; Benatti, Paola; Calvani, Menotti

Agent Lord and Company

Pub. Number AU-A-2008253134

PCT Pub. Number WO2008/141897

Priority 07108801.7 24.05.07 EP

Filing date 28 April 2008

Wipo publication date 27 November 2008

International Classifications

A61K 31/205 (2006.01)

A61K 31/365 (2006.01) - Lactones

A61K 31/4439 (2006.01)

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/141897 Priority application(s): WO2008/141897

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008253154-3,3-spiroindolinone derivatives

2008253125-Oral dosage form providing fast absorption of drug